Your browser doesn't support javascript.
loading
The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Weidhaas, Joanne B; Harris, Jonathan; Schaue, Dörthe; Chen, Allen M; Chin, Robert; Axelrod, Rita; El-Naggar, Adel K; Singh, Anurag K; Galloway, Thomas J; Raben, David; Wang, Dian; Matthiesen, Chance; Avizonis, Vilija N; Manon, Rafael R; Yumen, Omar; Nguyen-Tan, Phuc Felix; Trotti, Andy; Skinner, Heath; Zhang, Qiang; Ferris, Robert L; Sidransky, David; Chung, Christine H.
Afiliação
  • Weidhaas JB; Department of Radiation Oncology, David Geffen School of Medicine at UCLA (University of California, Los Angeles), Los Angeles, California.
  • Harris J; NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania.
  • Schaue D; Department of Radiation Oncology, David Geffen School of Medicine at UCLA (University of California, Los Angeles), Los Angeles, California.
  • Chen AM; Department of Radiation Oncology, David Geffen School of Medicine at UCLA (University of California, Los Angeles), Los Angeles, California.
  • Chin R; Department of Radiation Oncology, David Geffen School of Medicine at UCLA (University of California, Los Angeles), Los Angeles, California.
  • Axelrod R; Department of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • El-Naggar AK; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Singh AK; Roswell Park Cancer Institute, Buffalo, New York.
  • Galloway TJ; Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Raben D; Department of Radiation Oncology, University of Colorado at Denver, Aurora.
  • Wang D; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee.
  • Matthiesen C; Department of Radiation Oncology, Oklahoma University Health Sciences Center, Oklahoma City.
  • Avizonis VN; Department of Radiation Oncology, Intermountain Medical Center, Salt Lake City, Utah.
  • Manon RR; University of Florida Health Cancer Center, Orlando Health, Orlando.
  • Yumen O; Department of Radiation Oncology, Geisinger Medical Center CCOP, Danville, Pennsylvania.
  • Nguyen-Tan PF; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montreal, Montreal, Quebec, Canada.
  • Trotti A; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida.
  • Skinner H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Zhang Q; NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania.
  • Ferris RL; Cancer Immunology Program and Tumor Microvenvironment Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
  • Sidransky D; Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Chung CH; Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida.
JAMA Oncol ; 3(4): 483-491, 2017 Apr 01.
Article em En | MEDLINE | ID: mdl-28006059
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Proteínas Proto-Oncogênicas p21(ras) / Cetuximab / Neoplasias de Cabeça e Pescoço / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Proteínas Proto-Oncogênicas p21(ras) / Cetuximab / Neoplasias de Cabeça e Pescoço / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article